Global Collaboration Action for Research on Existing Malaria Therapeutics and Clinical Development of New Antimalarial Candidates
Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.
Unlike the standard Horizon Europe scoring pattern, this topic's second-stage full proposals use a 4/4/3 threshold: Excellence and Impact each need at least 4 out of 5, but Implementation only needs 3, with the three scores combined needing to reach at least 12 out of 15. Contributions from contributing partners feed directly into both the Impact and the Implementation scores, not just into the bu…
This topic wants research consortia to run Phase 2a-or-later clinical trials on new combinations of approved or novel antimalarial candidates, targeting children, pregnant women and immune-compromised people in high-transmission sub-Saharan African regions. It excludes prophylactic vaccine and monoclonal antibody development, and expects proposals to also cover long-term effectiveness data, pharmacovigilance, or evidence on drug resistance, with a clear path to regulatory approval and affordable access.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Horizon Europe Grants for Startups: A Founder Guide
A practical guide to Horizon Europe grants for startups, including EIC, consortia, eligibility, Funding & Tenders, TRL, budgets, and EU strategy.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from EDCTP3
All grants from this funder →Dr Pascoal Mocumbi Prize
🇪🇺EDCTP3 · European Union
Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.
Outstanding Female Scientist Prize
🇪🇺EDCTP3 · European Union
Awards EUR 20,000 to a woman scientist recognised for global-health research and mentorship in sub-Saharan Africa.
Outstanding Research Team Prize
🇪🇺EDCTP3 · European Union
Awards EUR 50,000 to a research team recognised for South-North global-health partnerships on poverty-related diseases.
Scientific Leadership Prize (Man, EU)
🇪🇺EDCTP3 · European Union
Awards EUR 15,000 to a male mid-career scientist based in the EU or an associated country for global-health leadership.
Scientific Leadership Prize (Man, SSA)
EDCTP3 · European Union
Awards EUR 15,000 to a male mid-career scientist based in sub-Saharan Africa for global-health leadership.
Scientific Leadership Prize (Woman, EU)
🇪🇺EDCTP3 · European Union
Awards EUR 15,000 to a woman mid-career scientist based in the EU or an associated country for global-health leadership.
Similar grants
Browse the directory →
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
STEP / Critical and Emerging Technologies — 14 (Tecnologie Critiche ed Emergenti)
🇮🇹MIMIT · Italy
Funds Italian companies in southern regions to develop critical innovation in climate, health, and materials.
Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens
🇪🇺European Commission · European Union
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.